Gimv invests in BioConnection

Gimv invests in BioConnection alongside current shareholders Pharming Group, Mibiton and management with the aim to accelerate the next stage of growth, and to facilitate further innovation in order to continue offering the best quality services to clients. The BOM has supported BioConnection since inception and has sold its shares.

Click here to read the press release

Target – BioConnection
Buyer – GIMV

Bridgepoint Advisers has agreed to acquire Alpha FMC

Bridgepoint Group Limited, the UK based private equity firm, through its UK based indirect subsidiary Actium Bidco (UK) Limited, has …

Read More →

Bridgepoint Advisers to make an offer for Alpha Financial

Bridgepoint Group Limited, the UK based private equity firm, through its UK based indirect subsidiary Actium Bidco (UK) Limited, has …

Read More →

Wakeo acquires Veroo Software

Wakeo, the France based provider of a SaaS platform providing real-time visibility on international transport flows (sea, air, road) to …

Read More →

Bregal Unternehmerkapital to acquire a majority stake in Relatech S.p.A.

Bregal Unternehmerkapital GmbH, the Germany based private equity firm, through Gemini BidCo, a special purpose vehicle indirectly controlled by the …

Read More →

DeepForm raises GBP 2m

DeepForm Limited, the UK based company, that specializes in developing and offering novel press tool designs, which help reduce material …

Read More →

PINOVA Capital invests in NEUROMEDEX

Neuromedex, the Germany based provider of disposable products for neurosurgery and intensive care, has been acquired by Pinova Capital GmbH, …

Read More →
close-link
close-link